This Healthcare Stock Rose Sharply On USPTO Issuance

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, February 19, 2025

A healthcare company based out of Salt Lake City is getting a lot of attention on Wednesday after the company announced the issuance of U.S. patent No. 12,239,761 by the United States Patent and Trademark Office, according to a press release.

Traders wasted no time snatching up shares of SiNtx Technologies Inc. (Nasdaq:SINT), pushing the micro cap up to $6.11/share (+116.67%) at the early session high. This move could be an indication of things to come as it appears this stock is attempting to breakout of a multi-month trading range.

SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.